Latest David B. Samadi Stories
NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Regular exercisers could be reducing their risk of prostate cancer by as much as 53 percent, though research suggests the benefit may only apply to white men. In polling the exercise habits of 307 men (164 Caucasian and 143 African American) undergoing prostate biopsies, researchers found an association between increased activity level in white men and reduced prostate cancer diagnosis. The same benefits were not seen among African American...
NEW YORK, Feb. 9, 2013 /PRNewswire/ -- On Saturday, February 16, 2013, top prostate cancer surgeon, Dr. David Samadi, will conduct free prostate cancer screenings at the Chian Federation, 4401 Broadway in Astoria, New York 11103. Prostate-specific antigen (PSA) blood tests and digital rectal exams (DRE) will be available at no charge from 2:30 pm to 6:30 pm. To schedule an appointment, men are asked to register at http://davidsamadi.eventbrite.com or call 718-204-2550. (Photo:...
NEW YORK, Feb. 5, 2013 /PRNewswire/ -- A new Prostate Cancer Outcomes Study (PCOS) in the January 31, 2013 New England Journal of Medicine, http://www.nejm.org/doi/full/10.1056/NEJMoa1209978 reported the functional status of men after robotic prostate surgery and external-beam radiation therapy (EBRT) for localized prostate cancer. Most men in the study (now ages 70-89) reported some problems with urinary control and sex after treatment for prostate cancer. Long-term side effects,...
NEW YORK, Jan. 25, 2013 /PRNewswire/ -- The impact of prostate cancer on American men will be significant in 2013, according to the "Cancer Facts & Figures 2013" report by the American Cancer Society (ACS) (http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf). The ACS projects that nearly 240,000 new cases of prostate cancer will account for 28 percent of all male cancers this year. Despite the disease's prevalence, prostate...
NEW YORK, Jan. 22, 2013 /PRNewswire/ -- Not all robots are created equal, particularly when it comes to prostate cancer, says world-renowned prostate cancer surgeon, Dr. David Samadi. Specializing in minimally invasive da Vinci robotic prostatectomy surgery, Dr. Samadi is not only Vice Chairman, Department of Urology at The Mount Sinai Medical Center; he is also Chief of Robotics and Minimally Invasive Surgery. (Photo: http://photos.prnewswire.com/prnh/20130122/NY45644 ) Robots...
NEW YORK, Jan. 11, 2013 /PRNewswire/ -- A comparative review of more than 230 previously published studies bumps radical prostate removal surgery above radiation in cost-effectiveness, quality of life after treatment, and patient survival. Surgery, whether performed traditionally, laparoscopically, or robotically, demonstrated improved outcomes across all three factors when compared to radiation for prostate cancer in the form of intensity-modulate radiation therapy, brachytherapy,...
NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Prostate cancer diagnoses may bring out the fight in men but patients need to know which punch to throw first. When diagnosed early, prostate cancer is highly treatable and patients most often choose between robotic prostate removal surgery or radiation for prostate cancer, including external beam radiation therapy (EBRT) and brachytherapy seed radiation. (Logo: http://photos.prnewswire.com/prnh/20130108/NY39190LOGO ) Three concerns drive...
Patients with muscle invasive bladder cancer may experience less loss of blood and shorter hospital stays as a result of robotic-assisted surgery, new randomized study in the Journal of Urology About 30 percent of the more than 70,000 bladder cancer cases expected in 2012 are muscle invasive. In such cases, radical cystectomy is the preferred treatment. In a pilot trial, a team of investigators assessed the efficacy of open radical cystectomy (ORC) vs. robotic-assisted laparoscopic radical...
NEW YORK, Dec. 18, 2012 /PRNewswire/ -- Sex after prostate cancer was the second most difficult thing to deal with for Canadian men who have or had prostate cancer. Even more difficult was maintaining hope, according to a prostate cancer study commissioned by Astellas Pharma Canada, Inc. and conducted online by Leger Marketing in October 2012. (Photo: http://photos.prnewswire.com/prnh/20121218/NY31740 )...
Can Talug, M.D., board-certified urologist and fellowship-trained in minimally invasive urologic oncology, is joining Dr. Carl Walker in the Urology Department at The South Bend Clinic. South Bend, Ind. (PRWEB) December 17, 2012 Can (pronounced John) Talug, M.D., is joining Dr. Carl Walker in the Urology Department at The South Bend Clinic. Previously, Dr. Talug was the assistant professor of urology and the associate urology residency program director at West Virginia University in...
